12:00 AM
 | 
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

SD-254: Phase I data

An open-label Phase I trial in 16 healthy volunteers showed that oral SD-254 had a pharmacokinetic profile...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >